Integrating conventional and antibody-based targeted anticancer treatment into immunotherapy.

Michelle Xu, M; Pu, Y; Weichselbaum, R R; Fu, Y-X

Michelle Xu, M; Pu, Y; Weichselbaum, R R; Fu, Y-X.

Afiliação

Michelle Xu M; Department of Pathology and Radiation Oncology, University of Chicago, Chicago, IL, USA.
Pu Y; Ludwig Center for Metastasis Research, University of Chicago, Chicago, IL, USA.
Weichselbaum RR; Department of Pathology and Immunology, The University of Texas Southwestern Medical Center, Dallas, TX, USA.
Fu YX; Department of Pathology and Radiation Oncology, University of Chicago, Chicago, IL, USA.

Oncogene ; 36(5): 585-592, 2017 02 02.

Article em En | MEDLINE | ID: mdl-27425593

Assuntos

Imunoterapia/métodos; Neoplasias/terapia; Animais; Anticorpos/imunologia; Terapia Combinada; Humanos; Terapia de Alvo Molecular; Neoplasias/imunologia; Neoplasias/patologia

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Imunoterapia / Neoplasias Tipo de estudo: Guideline Limite: Animals / Humans Idioma: En Ano de publicação: 2017 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google